Top

Published in:

01-06-2016 | Research Paper

MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo

Authors: Meng Zhu, Ning Zhang, Shuixiang He, Ruirui Yan, Jun Zhang

Published in: Clinical & Experimental Metastasis | Issue 5/2016

Abstract

Mounting evidences has shown that miRNAs are involved in the development and progression of gastric cancer acts as tumor suppressor genes or oncogenes. In our previous studies, we have found that the up-regulation of miR-106a occurs frequently in human gastric cancer tissues compared with that of normal tissues. Here, we investigate the role of the ectopic expressed miR-106a in the progression and metastasis of gastric cancer in vitro and in vivo. FFPE samples have the priority to be included and qRT-PCR was used to detect the miR-106a expression. Human gastric cancer cells and immortalized gastric epithelial cell were selected and the miR-106a mimic and inhibitor were transfected. Cell growth was determined by MTT method. The flow cytometric analysis for cell apoptosis and transwell assays for evaluating the cell migration and invasion were conducted. Luciferase assay and western blot confirmed the direct binding site of miR-106a and its target. BALB/c nude mice were randomly divided to explore the implantation of gastric cancer cells transfected with miR-106a antagomir. Abnormal over-expression of miR-106a significantly promoted gastric cancer cell proliferation, metastasis, inhibited the cell apoptosis. Functional experiment ascertained that miR-106a interacted with FAS and mediated caspase3 pathway. Knockdown of miR-106a leaded to the attenuation of gastric cancer implantation capacity in vivo. Moreover, expression of TIMP2 was inversely associated with miR-106a in nodule tissues. Apoptotic body was also seen under electron microscope accompanied by silencing of miR-106a. Together, this data indicated that miR-106a may act as an oncogene and contribute to gastric cancer development.

GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 (2014) http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=all. Accessed 22 July 2014

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. doi:10.3322/caac.21262 CrossRefPubMed

Piazuelo MB, Correa P (2013) Gastric cancer: overview. Colomb Med 44(3):192–201PubMed

Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482(7385):347–355. doi:10.1038/nature10888 CrossRefPubMedPubMedCentral

Schirle NT, Sheu-Gruttadauria J, MacRae IJ (2014) Structural basis for microRNA targeting. Science 346(6209):608–613. doi:10.1126/science.1258040 CrossRefPubMedPubMedCentral

Kloosterman WP, Plasterk RH (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11(4):441–450. doi:10.1016/j.devcel.2006.09.009 CrossRefPubMed

Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175–205. doi:10.1146/annurev.cellbio.23.090506.123406 CrossRefPubMed

Landais S, Landry S, Legault P, Rassart E (2007) Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67(12):5699–5707. doi:10.1158/0008-5472.can-06-4478 CrossRefPubMed

Li P, Xu Q, Zhang D, Li X, Han L, Lei J, Duan W, Ma Q, Wu Z, Wang Z (2014) Upregulated miR-106a plays an oncogenic role in pancreatic cancer. FEBS Lett 588(5):705–712. doi:10.1016/j.febslet.2014.01.007 CrossRefPubMed

10.

Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma LN, Xu SL, Yang L, Wang QL, Dang WQ, Cui W, Yu SC, Ping YF, Cui YH, Kung HF, Qian C, Zhang X, Bian XW (2014) Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene. doi:10.1038/onc.2014.75

11.

Hong L, Lai M, Chen M, Xie C, Liao R, Kang YJ, Xiao C, Hu WY, Han J, Sun P (2010) The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res 70(21):8547–8557. doi:10.1158/0008-5472.CAN-10-1938 CrossRefPubMedPubMedCentral

12.

Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F, Yan D (2015) Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer. Cancer Sci 106(10):1323–1332. doi:10.1111/cas.12759 CrossRefPubMedPubMedCentral

13.

Zhu M, Zhang N, He S, Lui Y, Lu G, Zhao L (2014) MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer. FEBS Lett 588(4):600–607. doi:10.1016/j.febslet.2013.12.028 CrossRefPubMed

14.

Zhu M, Zhang N, He S (2014) Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development. Pathol Res Pract 210(12):909–915. doi:10.1016/j.prp.2014.07.008 CrossRefPubMed

15.

Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C, Quan L, Bai J, Xu N (2013) miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol Carcinog 52(8):634–646. doi:10.1002/mc.21899 CrossRefPubMed

16.

Fox JG, Wang TC (2007) Inflammation, atrophy, and gastric cancer. J Clin Investig 117(1):60–69. doi:10.1172/JCI30111 CrossRefPubMedPubMedCentral

17.

Goubran HA, Kotb RR, Stakiw J, Emara ME, Burnouf T (2014) Regulation of tumor growth and metastasis: the role of tumor microenvironment. Cancer Growth Metastasis 7:9–18. doi:10.4137/CGM.S11285 CrossRefPubMedPubMedCentral

18.

Cullen SP, Martin SJ (2015) Fas and TRAIL ‘death receptors’ as initiators of inflammation: implications for cancer. Semin Cell Dev Biol 39:26–34. doi:10.1016/j.semcdb.2015.01.012 CrossRefPubMed

19.

Vilmont V, Filhol O, Hesse AM, Coute Y, Hue C, Remy-Tourneur L, Mistou S, Cochet C, Chiocchia G (2015) Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD). Biochim Biophys Acta 1853(11 Pt A):2885–2896. doi:10.1016/j.bbamcr.2015.08.001 CrossRefPubMed

20.

Walczak H, Krammer PH (2000) The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256(1):58–66. doi:10.1006/excr.2000.4840 CrossRefPubMed

21.

Lavrik IN (2014) Systems biology of death receptor networks: live and let die. Cell Death Dis 5:e1259. doi:10.1038/cddis.2014.160 CrossRefPubMedPubMedCentral

22.

Yu D, Shin HS, Lee YS, Lee YC (2014) miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells. Lab Investig 94(12):1370–1381. doi:10.1038/labinvest.2014.125 CrossRefPubMed

23.

Moon YW, Jeung HC, Rha SY, Yoo NC, Roh JK, Noh SH, Kim BS, Chung HC (2007) Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Ann Surg Oncol 14(10):2730–2737. doi:10.1245/s10434-007-9479-4 CrossRefPubMed

24.

Glockzin G, Piso P (2012) Current status and future directions in gastric cancer with peritoneal dissemination. Surg Oncol Clin N Am 21(4):625–633. doi:10.1016/j.soc.2012.07.002 CrossRefPubMed

25.

Coccolini F, Gheza F, Lotti M, Virzi S, Iusco D, Ghermandi C, Melotti R, Baiocchi G, Giulini SM, Ansaloni L, Catena F (2013) Peritoneal carcinomatosis. World J Gastroenterol 19(41):6979–6994. doi:10.3748/wjg.v19.i41.6979 CrossRefPubMedPubMedCentral

26.

Goseki N, Takizawa T, Koike M (1992) Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 33(5):606–612CrossRefPubMedPubMedCentral

27.

Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90(9):1113–1119. doi:10.1002/bjs.4164 CrossRefPubMed

28.

Mei LJ, Yang XJ, Tang L, Hassan AH, Yonemura Y, Li Y (2010) Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer. BMC Cancer 10:124. doi:10.1186/1471-2407-10-124 CrossRefPubMedPubMedCentral

29.

Liotta LA, Stetler-Stevenson WG (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51(18 Suppl):5054s–5059sPubMed

30.

Murphy G (2011) Tissue inhibitors of metalloproteinases. Genome Biol 12(11):233. doi:10.1186/gb-2011-12-11-233 CrossRefPubMedPubMedCentral

31.

Murphy G, Nagase H (2008) Progress in matrix metalloproteinase research. Mol Aspects Med 29(5):290–308. doi:10.1016/j.mam.2008.05.002 CrossRefPubMedPubMedCentral

32.

Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52–67. doi:10.1016/j.cell.2010.03.015 CrossRefPubMedPubMedCentral

Title: MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo
Authors: Meng Zhu
Ning Zhang
Shuixiang He
Ruirui Yan
Jun Zhang
Publication date: 01-06-2016
Publisher: Springer Netherlands
Published in: Clinical & Experimental Metastasis / Issue 5/2016
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-016-9795-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2016

Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options

Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells

Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA

Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines

Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells

Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer